Symptom Burden After Completion of Tuberculosis Therapy in REMoxTB

C. Tweed (London, United Kingdom), G. Wills (London, United Kingdom), J. Meghji (Liverpool, United Kingdom)

Source: International Congress 2022 – Advances in epidemiology, diagnosis and treatment of tuberculosis

Session: Advances in epidemiology, diagnosis and treatment of tuberculosis
Session type: Oral Presentation
Number: 760

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Tweed (London, United Kingdom), G. Wills (London, United Kingdom), J. Meghji (Liverpool, United Kingdom). Symptom Burden After Completion of Tuberculosis Therapy in REMoxTB. 760

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.